AMAG Pharmaceuticals (AMAG) PT Raised to $24 at Morgan Stanley
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Morgan Stanley raised its price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $24.00 (from $22.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- HCA Healthcare Inc (HCA) PT Lowered to $425 at JPMorgan
- Shanghai Conant Optical (2276:HK) PT Lowered to HK$81.40 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
